Pfizer

4 statements across 4 episodes · 2 bullish · 0 bearish · 4 people on the record · first statement Jul 10, 2024 by Matt Wood · said 7 times in 7 episodes since 2023 · across every show →

Mentions by year

brought up most by Swami Sivasubramanian (1), Peter Diamandis (1), Matt Wood (1), Marty Brodbeck (1), Dario Amodei (1), Alex Kantrowitz (1), Aaron Levie (1)

tap a year for its mentions
002233202320242025episodesmentions
023202320242025episodes it came up in
000.51.513202320242025episodesmentions per episode

every mention, scene by scene, with the transcript →

Everything said about Pfizer, oldest first

Jul 10, 2024 bullish
Disclosure
Wood: AWS worked with EvolutionaryScale on generative AI drug discovery
“Pfizer or the work we've done with a startup called evolutionary scale to be able to use generative AI to be able to design entirely to entirely new molecules to design entirely new antibodies that are manufacturable that can go on and find new drug targets. L…”
Matt Wood Jul 10, 2024 ▶ 9:29 Amazon's Longterm AI Vision — With AWS VP Matt Wood
Jul 29, 2024 neutral
Assertion Partly supported
Diamandis: Moderna and Pfizer mRNA vaccines cost two dollars each to make
“So our mRNA vaccines from Moderna or Pfizer were gene therapies and they cost two bucks each, right? They were sold for 20 bucks or whatever the case might be. So we know that you can mass produce gene therapies extraordinarily cheaply.”
Peter Diamandis Jul 29, 2024 ▶ 46:25 Peter Diamandis — Embracing AI, Befriending Elon, And Living Forever
Aug 6, 2025 positive
Assertion Supported
Kantrowitz: Anthropic works with Pfizer, United Airlines, and AIG
“So they are working with companies and industries like travel, healthcare, financial services, insurance companies like Pfizer, United airlines, and AIG to implement this technology within their workflows. And it's not just coding.”
Alex Kantrowitz Aug 6, 2025 ▶ 16:27 Anthropic’s Potential, AI Video Gets Crazy, Market Bubble Approaching?
Sep 18, 2025 neutral
Prediction Not checkable as stated
Levie: Pfizer And Eli Lilly Won't Be Disrupted By Delayed AI Adoption
“Like if Pfizer or Eli Lilly took a little bit longer to adopt AI as a result of, you know, wanting to be more pragmatic, that'll be totally fine. They're not going to get disrupted. Like they have enough of market position. They have enough distribution. They …”
Aaron Levie Sep 18, 2025 ▶ 24:05 Are 95% of Businesses Really Getting No Return on AI Investment? — With Aaron Levie
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.